The Cooper Companies, Inc. vs Johnson & Johnson
COO vs JNJ — side-by-side comparison from reported financials. COO leads 4, JNJ leads 7 of 11 comparable metrics.
The Cooper Companies, Inc.
COO · Healthcare
$54.37+0.13%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | COO | JNJ |
|---|---|---|
| Price | $54.37 | $261.79 |
| Market cap | $10.3B | $631B |
| Revenue (TTM) | $4.24B | $97.9B |
| Revenue growth | +7.3% | +5.6% |
| Net margin | 13.5% | 21.5% |
| Free cash flow | $678M | $22.2B |
| Net cash (debt) | ($2.39B) | ($27.8B) |
| 1-year price return | -22.1% | +37.0% |
| P/E | 18.1 | 29.9 |
| P/E vs own history (cheap-side %) | 89% | 16% |
| Dividend yield | 0.00% | 2.00% |
| Return on equity | 7% | 26% |
| CV checks passed | 8 of 11 | 10 of 11 |
| Employees | 15,000 | 140,800 |
Full résumé-style profiles: COO CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.